Yuri

Yuri is a space biotech company founded in 2019 and headquartered in Germany. The company's slogan, "Space biotech for a better life 🧫🚀," reflects its core mission. Yuri utilizes the unique microgravity environment of space to advance biotech products. With a team of 30+ space engineers and biologists, Yuri has collaborated with renowned organizations including NASA, ESA, GSK, and Charité Berlin, and has worked on 20+ payloads for the International Space Station.

Yuri's focus lies in the development of modular bioreactors and incubators for various applications such as cell cultures, protein crystals, and plants. These products are sent to the ISS and other spacecraft, including the Sierra Nevada Dream Chaser and SpaceX Dragon, offering scientists worldwide access to these cutting-edge tools. Additionally, the company offers devices for simulating microgravity on Earth, such as the Random Positioning Machine (RPM) and the Clinostat.

In its latest funding round in June 2021, Yuri secured investment from Nucleus Capital, Apex Ventures, 50Y, Possible Ventures, and Selvedge Venture. With its innovative approach and strong partnerships, Yuri is poised to make a significant impact within the hardware, manufacturing, and space industries.